Healthcare IT News - October 2007 - (Page 51)

www.HealthcareITNews.com VENdoRS October 2007 ■ Healthcare IT News 51 Cognos adds to BI offerings with Applix deal By ErIC WICkluNd, Managing Editor WESTBORO, MA – Activity in the busi- ness analytics market picked up a notch last month with the announcement that Applix, Inc. would be acquired by Ottawa-based business intelligence provider Cognos, Inc. for roughly $339 million. Applix, a publicly held company based in Westboro, Mass. with more than 3,000 customers, supplies business performance management (BPM) solutions to a wide range of fields, including the healthcare sector. The company is expected to complement Cognos’ flagship products – Cognos 8 Planning, Cognos 8 Controller and Cognos 8 Business Intelligence. Particularly appealing, Cognos officials say, is Applix’s TM1 OLAP (online analytical processing) engine, which would boost Cognos’ performance management software by adding profitability, customer and product analysis capabilities. “Applix will broaden our solution offering and provide Cognos with an innovative, 64-bit, inmemory analytics capability,” said Rob Ashe, CEO of Cognos. “It will also bring into the company a very strong employee and customer base that has been committed to performance management through high-impact analytics.” In a conference call last month, Ashe emphasized that Applix’s TMI would not overlap with Cognos’ own OLAP server, PowerPlay. Cognos had reported a strong first quarter, with $22.4 million in profits based on $236.7 million in revenue, positioning it in a crowded, $6.25 billion business performance and analytics software field that includes Business Objects, Oracle and SAP. The Cognos deal is just the latest in a string of announcements related to the field, highlighted by Business Objects’ acquisitions of Inxight Software, Cartesis and NSite Software and its release of Crystal Decisions this year, SAP’s purchase of OutlookSoft and Oracle’s $3.3 billion purchase of Hyperion in April. “They’re all trying to round out their business analytics platforms,” said David Corbett, a project manager at Applix, in an interview two months ago. “As the healthcare field becomes more competitive, business analytics becomes more and more important.” Analysts have called the deal pricey, since it will cost Cognos more than $300 million but bring in just $60 million in revenue. According to a Dow Jones Newswire report, Cognos has been rumored for months to be a target itself for acquisition, with Oracle and IBM mentioned most frequently as suitors. ■ More at HealthcareITNews.com e Connect: coGNoS 1007 ©2007 First DataBank, Inc. ● dosINg Continued from page 49 WITH ORDERVIEW, THEY GET IT TUNED TO THEIR NEEDS. (Now ordering meds is quick and easy.) Finally. There’s a drug database designed speciﬁcally to help make your CPOE system more user-friendly. The OrderView Med Knowledge Base™ uses pre-built med orderables to enable physicians to order precisely the meds they need in the fewest possible steps— easily, intuitively and without frustration. OrderView includes doses and frequencies, IV to PO conversions, and renal and hepatic adjustments to make the med ordering process even more efﬁcient and convenient. Simply put, OrderView is built to accommodate the way a clinician thinks, leading to faster acceptance of CPOE, more successful implementation, and better patient outcomes. Ask your CPOE system vendor about OrderView. Or visit ﬁrstdatabank.com to download our white paper or a free set of sample orders. To schedule a demo, call 800-633-3453. doctors to calculate the best doses for single or multiple drugs. The Web-based portal, officials say, uses proprietary dose-response technology that takes into account a patient’s previous doses and responses to calculate future doses. In other words, a diabetic patient can program his or her bloodglucose readings and past insulin doses into myHealthManager and determine how much insulin to take and when it’s needed. While IDS allows the patient to make the decisions, Bonham said it also allows the physician to track a patient’s medical progress through EndoPHR and make any changes that are necessary. She emphasized that this isn’t a stand-alone PHR, as there is physician oversight. “They can go in anytime and see how the patient is doing” without having that patient come to the office for a check-up, she said. Both Bonham and John McMichael, the CEO of Dimensional Dosing Systems, say IDS will eventually be adapted to other situations that involve medication monitoring. Among Dimensional Dosing’s other products is the MultiAgent Intelligent Dosing Systems (MAIDS), which help keep track of more than one therapy. “We are very pleased that a dynamic company like RemedyMD is adding our proprietary dosing technology to its suite of electronic medical software offerings,” McMichael said. “We look forward to growing with them and expanding the use of the IDS beyond diabetes and insulin to other important therapy areas.” ■ More at HealthcareITNews.com e Connect: DoSiNG 1007 e ● Connect: FirStDataBaNK 1007 ● http://www.HealthcareITNews.com http://HealthcareITNews.com http://www.healthcareitnews.com/story.cms?id=7865 http://www.firstdatabank.com http://www.firstdatabank.com http://HealthcareITNews.com http://www.healthcareitnews.com/story.cms?id=7860 http://www.healthcareitnews.com/eConnect.cms?id=7920

Table of Contents Feed for the Digital Edition of Healthcare IT News - October 2007

Healthcare IT News - October 2007 Contents Global Harmony Telegrowth New Rules Keeping Tabs What's Free? PHR of Its Own Intelligent Closing Practice Management Paper Tiger

Healthcare IT News - October 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.